Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel

Background<p>Tumor promoters enhance tumor yield in experimental animals without directly affecting the DNA of the cell. Promoters may play a role in the development of cancer, as humans are exposed to them in the environment. In work based on computer-assisted microscopy and sophisticated cla...

Full description

Bibliographic Details
Main Authors: Karunananda Bombuwala, Thomas Kinstle, Vladimir Popik, Sonal O. Uppal, James B. Olesen, Jose Viña, Carol A. Heckman
Format: Article
Language:English
Published: Beilstein-Institut 2006-06-01
Series:Beilstein Journal of Organic Chemistry
Online Access:https://doi.org/10.1186/1860-5397-2-13
_version_ 1818445091148136448
author Karunananda Bombuwala
Thomas Kinstle
Vladimir Popik
Sonal O. Uppal
James B. Olesen
Jose Viña
Carol A. Heckman
author_facet Karunananda Bombuwala
Thomas Kinstle
Vladimir Popik
Sonal O. Uppal
James B. Olesen
Jose Viña
Carol A. Heckman
author_sort Karunananda Bombuwala
collection DOAJ
description Background<p>Tumor promoters enhance tumor yield in experimental animals without directly affecting the DNA of the cell. Promoters may play a role in the development of cancer, as humans are exposed to them in the environment. In work based on computer-assisted microscopy and sophisticated classification methods, we showed that cells could be classified by reference to a database of known normal and cancerous cell phenotypes. Promoters caused loss of properties specific to normal cells and gain of properties of cancer cells. Other compounds, including colchicine, had a similar effect. Colchicine given together with paclitaxel, however, caused cells to adopt properties of normal cells. This provided a rationale for tests of microtubule inhibitor combinations in cancer patients. The combination of a depolymerizing and a stabilizing agent is a superior anti-tumor treatment. The biological basis of the effect is not understood.</p><p>Results</p><p>A single compound containing both colchicine and paclitaxel structures was synthesized. Colchicine is an alkaloid with a trimethoxyphenyl ring (ring A), a ring with an acetamide linkage (ring B), and a tropolone ring (ring C). Although rings A and C are important for tubulin-binding activity, the acetamide linkage on ring B could be replaced by an amide containing a glutamate linker. Alteration of the C-7 site on paclitaxel similarly had little or no inhibitory effect on its biological activity. The linker was attached to this position. The coupled compound, colchitaxel (1), had some of the same effects on microtubules as the combination of starting compounds. It also caused shortening and fragmentation of the + end protein cap.</p><p>Conclusion</p><p>Since microtubule inhibitor combinations give results unlike those obtained with either inhibitor alone, it is important to determine how such combinations affect cell shape and growth. Colchitaxel shows a subset of the effects of the inhibitor combination. Thus, it may be able to bind the relevant cellular target of the combination. It will be useful to determine the basis of the shape reversal effect and possibly, the reasons for therapeutic efficacy of microtubule inhibitor combinations.</p>
first_indexed 2024-12-14T19:26:19Z
format Article
id doaj.art-32e97f442cec4b1abd7e7b39e1783d8f
institution Directory Open Access Journal
issn 1860-5397
language English
last_indexed 2024-12-14T19:26:19Z
publishDate 2006-06-01
publisher Beilstein-Institut
record_format Article
series Beilstein Journal of Organic Chemistry
spelling doaj.art-32e97f442cec4b1abd7e7b39e1783d8f2022-12-21T22:50:12ZengBeilstein-InstitutBeilstein Journal of Organic Chemistry1860-53972006-06-01211310.1186/1860-5397-2-131860-5397-2-13Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxelKarunananda Bombuwala0Thomas Kinstle1Vladimir Popik2Sonal O. Uppal3James B. Olesen4Jose Viña5Carol A. Heckman6Department of Chemistry, Bowling Green State University, Bowling Green, OH 43403, USADepartment of Chemistry, Bowling Green State University, Bowling Green, OH 43403, USADepartment of Chemistry, Bowling Green State University, Bowling Green, OH 43403, USADepartment of Chemistry, Bowling Green State University, Bowling Green, OH 43403, USABiology Department, Ball State University, Muncie, IN 47306, USAScientific Volume Imaging BV, Alexanderlaan 14, 1213 XS Hilversum, The NetherlandsCenter for Microscopy & Microanalysis, Bowling Green State University, Bowling Green, OH 43403, USABackground<p>Tumor promoters enhance tumor yield in experimental animals without directly affecting the DNA of the cell. Promoters may play a role in the development of cancer, as humans are exposed to them in the environment. In work based on computer-assisted microscopy and sophisticated classification methods, we showed that cells could be classified by reference to a database of known normal and cancerous cell phenotypes. Promoters caused loss of properties specific to normal cells and gain of properties of cancer cells. Other compounds, including colchicine, had a similar effect. Colchicine given together with paclitaxel, however, caused cells to adopt properties of normal cells. This provided a rationale for tests of microtubule inhibitor combinations in cancer patients. The combination of a depolymerizing and a stabilizing agent is a superior anti-tumor treatment. The biological basis of the effect is not understood.</p><p>Results</p><p>A single compound containing both colchicine and paclitaxel structures was synthesized. Colchicine is an alkaloid with a trimethoxyphenyl ring (ring A), a ring with an acetamide linkage (ring B), and a tropolone ring (ring C). Although rings A and C are important for tubulin-binding activity, the acetamide linkage on ring B could be replaced by an amide containing a glutamate linker. Alteration of the C-7 site on paclitaxel similarly had little or no inhibitory effect on its biological activity. The linker was attached to this position. The coupled compound, colchitaxel (1), had some of the same effects on microtubules as the combination of starting compounds. It also caused shortening and fragmentation of the + end protein cap.</p><p>Conclusion</p><p>Since microtubule inhibitor combinations give results unlike those obtained with either inhibitor alone, it is important to determine how such combinations affect cell shape and growth. Colchitaxel shows a subset of the effects of the inhibitor combination. Thus, it may be able to bind the relevant cellular target of the combination. It will be useful to determine the basis of the shape reversal effect and possibly, the reasons for therapeutic efficacy of microtubule inhibitor combinations.</p>https://doi.org/10.1186/1860-5397-2-13
spellingShingle Karunananda Bombuwala
Thomas Kinstle
Vladimir Popik
Sonal O. Uppal
James B. Olesen
Jose Viña
Carol A. Heckman
Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel
Beilstein Journal of Organic Chemistry
title Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel
title_full Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel
title_fullStr Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel
title_full_unstemmed Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel
title_short Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel
title_sort colchitaxel a coupled compound made from microtubule inhibitors colchicine and paclitaxel
url https://doi.org/10.1186/1860-5397-2-13
work_keys_str_mv AT karunanandabombuwala colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel
AT thomaskinstle colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel
AT vladimirpopik colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel
AT sonalouppal colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel
AT jamesbolesen colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel
AT josevina colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel
AT carolaheckman colchitaxelacoupledcompoundmadefrommicrotubuleinhibitorscolchicineandpaclitaxel